Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 7 | Arthritis Research & Therapy

Figure 7

From: PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

Figure 7

PDL241 had no effect on clinical parameters in the rhesus monkey CIA model. The analysis of all animals showed no effect of PDL241 on (A) bodyweight loss relative to day 0; (B) average clinical score; and (C) serum CRP levels. PDL241 treatment had no effect on (D) disease free survival or (E) overall survival. CIA, collagen-induced arthritis; CRP, C-reactive protein.

Back to article page